PSEUDOMONAS-AERUGINOSA IMMUNOTHERAPY

被引：8

作者：

PENNINGTON, JE ^{[1
]}

机构：

[1] UNIV CALIF SAN FRANCISCO, DEPT MED, SAN FRANCISCO, CA 94143 USA

来源：

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES | 1990年 / 9卷 / 06期

关键词：

D O I：

10.1007/BF01979465

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：377 / 380

页数：4

共 37 条

[21]

PENNINGTON J E, 1986, Journal of Critical Care, V1, P4, DOI 10.1016/S0883-9441(86)80111-3

[22] POLYCLONAL AND MONOCLONAL-ANTIBODY THERAPY FOR EXPERIMENTAL PSEUDOMONAS-AERUGINOSA PNEUMONIA [J].

PENNINGTON, JE ;

SMALL, GJ ;

LOSTROM, ME ;

PIER, GB .

INFECTION AND IMMUNITY, 1986, 54 (01) :239-244

[23]

PENNINGTON JE, 1979, PSEUDOMONAS AERUGINO, P191

[24] IMMUNOCHEMICAL CHARACTERIZATION OF THE MUCOID EXOPOLYSACCHARIDE OF PSEUDOMONAS-AERUGINOSA [J].

PIER, GB ;

MATTHEWS, WJ ;

EARDLEY, DD .

JOURNAL OF INFECTIOUS DISEASES, 1983, 147 (03) :494-503

[25] ISOLATION AND CHARACTERIZATION OF A HIGH-MOLECULAR-WEIGHT POLYSACCHARIDE FROM SLIME OF PSEUDOMONAS-AERUGINOSA [J].

PIER, GB ;

SIDBERRY, HF ;

ZOLYOMI, S ;

SADOFF, JC .

INFECTION AND IMMUNITY, 1978, 22 (03) :908-918

[26] SAFETY AND IMMUNOGENICITY OF HIGH MOLECULAR-WEIGHT POLYSACCHARIDE VACCINE FROM IMMUNOTYPE-1 PSEUDOMONAS-AERUGINOSA [J].

PIER, GB .

JOURNAL OF CLINICAL INVESTIGATION, 1982, 69 (02) :303-308

[27]

POLK HC, 1973, ANN SURG, V177, P607

[28] SPECIFICITY OF OPSONIC ANTIBODIES TO ENHANCE PHAGOCYTOSIS OF PSEUDOMONAS-AERUGINOSA BY HUMAN ALVEOLAR MACROPHAGES [J].

REYNOLDS, HY ;

KAZMIEROWSKI, JA ;

NEWBALL, HH .

JOURNAL OF CLINICAL INVESTIGATION, 1975, 56 (02) :376-385

[29] PSEUDOMONAS-AERUGINOSA INFECTIONS - PERSISTING PROBLEMS AND CURRENT RESEARCH TO FIND NEW THERAPIES [J].

REYNOLDS, HY ;

LEVINE, AS ;

WOOD, RE ;

ZIERDT, CH ;

DALE, DC ;

PENNINGTON, JE .

ANNALS OF INTERNAL MEDICINE, 1975, 82 (06) :819-831

[30]

ROE EA, 1983, REV INFECT DIS, V5, pS922

← 1 2 3 4 →